Litigation
Feb. 1, 2012
Generic drug suits gets legs
The U.S. Supreme Court swept the legs out from under patients with product liability lawsuits against generic drug manufacturers last year, but those plaintiffs are getting back on their feet.
Daily Journal Staff Writer
The U.S. Supreme Court swept the legs out from under patients with product liability lawsuits against generic drug manufacturers last year, but those plaintiffs are getting back on their feet.
The high court said in Pliva v. Mensing that plaintiffs could not sue generic drugmakers under state failure-to-warn laws because federal regulations regarding medicine labels preempted those claims. ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In